This finding may indicate a need to genotype AD patients for ALDH2 when using blood NFL as a potential neurotoxic indicator for clinical diagnosis, evaluation of alcohol-induced neuroaxonal injury, and monitoring of treatment outcomes. The gene discussed is ALDH2; the disease is Alzheimer disease.